Cellular Mechanism of Disease, Genetics, Medicine
His lab develops and applies cutting-edge technologies to investigate the function and mechanism of transcription, the genetic basis of complex phenotypes and the genetic and molecular systems underpinning disease. Their ultimate goal is to enable the development of personalized, preventative medicine.
In parallel to his research activities at Stanford, Lars continues to lead his lab at EMBL. His Stanford and EMBL labs collaborate very closely.
At EMBL, the Steinmetz group develops and applies interdisciplinary, genome-wide technologies to study genome regulation, the genetic basis of complex phenotypes and the genetic and molecular systems underpinning disease.